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INTRODUCTION
Oral administration is the most commonly used route for drug 
administration due to its convenience, high level of patient safety, and 
the relatively low production cost. For efficiency, drugs designed to be 
systemically active must be absorbed from the site of administration [1]. 
The effectiveness of oral systemic drugs is affected by pharmacokinetic 
properties, involving absorption, distribution, metabolism, and 
excretion.
The major steps occurring during the absorption of oral drugs are the 
dissolution of the drug from the dosage form, the solubility of the drug, 
the drug’s effective permeability to the intestinal mucosa, and the drug’s 
pre-systemic metabolism [2]. Dissolution is the process by which a solid 
drug substance dissolves in a solvent over time [3]. Solubility is the mass 
of solute that dissolves in a specific mass or volume of solvent at a given 
temperature. Thus, the solubility test may be used to predict bioavailability.
Noyes–Whitney equation reveals that dissolution may be affected 
by the physicochemical characteristics of the drug, formulation, and 
solvent [4]. The permeation of drug across the gut wall (a model lipid 
membrane) is affected by the ability of the drug to diffuse (D) and 
partition between the lipid membranes. Further, the aqueous solubility 
of the drug can be estimated by aqueous environments, depending on 
the ionization of the tested drug [5].
Furthermore, most drugs are weakly acidic or weakly basic 
compounds [6]. Weakly acidic and weakly basic compounds cannot 
completely ionize in aqueous media, which are appropriate because 
unionized drugs, as opposed to ionized drugs, tend to exhibit 
considerably greater lipid solubility. In addition to their effect on 
dissolution kinetics, the physicochemical properties of the drug such 
as pKa and pH profile, particle size, polymorphism, hygroscopicity, and 
partition coefficient are important properties in drug designing [3].
This study analyzed the absorption of drugs in the body using in silico 
method. The solubility and permeability of the intestine toward the 
drug are considered the two most important determinants of the 
bioavailability of oral drugs. Moreover, the bioavailability of the drug 
may be reduced by efflux mechanism or first-pass metabolism in the 
intestine and/or liver. This study aimed to observe the pharmacokinetic 
parameters that can be predicted using software, discover the best 
software to predict pharmacokinetic properties, and analyze the 
correlation between pharmacokinetic parameters used as descriptors 
with absorption percentage (%ABS) from reference.
METHODS
Hardware and software
Two computers with the following specifications were used. The first 
computer had a Quad-Core Processor CPU Q9400 @ 2.67 GHz (Intel® 
Core TM, America), system type 64-bit operating system, and Windows 
operating system. The second computer had an Intel® Core™ i5-4210U 
CPU @ 1.70GHz (4 CPUs), ~2.4GHz, 8192MB RAM, and Windows 10 
Home 64-bit (10.0, Build 16299).
The software used was admetSAR (Shanghai Key Laboratory 
of New Drug Design, China) [7], SwissADME (Swiss Institute of 
Bioinformatics, Swiss) [8], QikProp (Schrodinger, LLC, New York, 
United States of America)[9], Chemicalize (ChemAxon Ltd., Budapest, 
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ABSTRACT
Objective: This research aims to observe the pharmacokinetic parameters that can be predicted using a software, discover the best software to predict 
pharmacokinetic properties, and analyze the correlation between pharmacokinetic parameters used as descriptors with absorption percentage 
(%ABS) from references.
Methods: This research was conducted using Molinspiration, QikProp, admetSAR, SwissADME, Chemicalize, and pkCSM software. This research 
analyzed 34 oral systemic drug compounds for absorption rate and six descriptors comprising molecular weight (MW), logP, hydrogen bond acceptor 
(HBA), hydrogen bond donor (HBD), polar surface area (PSA), and pKa.
Results: SwissADME showed the most accurate prediction of MW, logP, and HBD. Chemicalize showed the most accurate prediction of HBA, PSA, and 
pKa. Further, admetSAR showed the most accurate prediction of Caco-2 permeability. The highest R value was obtained from the correlation between 
%ABS with Caco-2 permeability on 34 drug compounds (R=0.8211).
Conclusion: The highest R value was obtained from the correlation between %ABS with Caco2 permeability on 34 drug compounds (R=0.8211), 
which showed a significant relationship (*p<0.001). This indicates that oral systemic drugs are affected by Caco-2 permeability. Moreover, the result 
of this research can be considered for the development of oral systemic drugs.
Keywords: Absorption percentage, Absorption, distribution, metabolism, and excretion prediction, In silico, Oral systemic drugs, Physicochemical 
parameters, Pharmacokinetic parameters.
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Hungary) [10], pkCSM (Biosig Lab, University of Melbourne, 
Australia) [11], Molinspiration (Molinspiration Cheminformatics, 
Slovak Republic) [12], and Microsoft Excel.
Drug compounds
The drug compounds used in this research were two-dimensional 
structures of aminopyrine, cimetidine, ciprofloxacin, cromolyn sodium, 
cyclosporin, dexamethasone, doxorubicin, famotidine, fenoterol, 
hydrocortisone, ibuprofen, indomethacin, isoxicam, ketorolac, 
lansoprazole, lornoxicam, meloxicam, metaproterenol, methotrexate, 
methylprednisolone, naproxen, nizatidine, omeprazole, oxatomide, 
piroxicam, prednisolone, ranitidine, salicylic acid, sulindac, sumatriptan, 
tenidap, tenoxicam, terbutaline, and theophylline. The two-dimensional 
structures of the 34 drug compounds were downloaded from PubChem.
Preparation of two-dimensional drug compounds
The preparation of the structures of the drug compounds includes 
searching, selecting, downloading, and converting the structures from 
two-dimensional to three-dimensional; further, these drug compound 
structures were prepared using the information obtained from the 
database and bioinformatics website PubChem and MarvinSketch.
Preparation of experimental pharmacokinetic parameters
The pharmacokinetic parameters that were evaluated were %ABS, 
molecular weight (MW), logP, hydrogen bond acceptor (HBA), 
hydrogen bond donor (HBD), polar surface area (PSA), pKa, and Caco-2 
permeability. The data were collected from Zhao et al. [13] and previous 
researches [14-33].
Validation of predicted pharmacokinetic parameters
Validation was performed to predict the pharmacokinetic parameters 
(MW, logP, HBA, HBD, PSA, pKa, and Caco-2 permeability) of the 34 drug 
compounds using Molinspiration, admetSAR, SwissADME, QikProp, 
Chemicalize, and pkCSM.
Optimization of predicted pharmacokinetic parameters
By comparing experimental data from the reference with the software-
predicted data from multiple software, optimization was performed to 
determine the software that showed the most accurate prediction of the 
pharmacokinetic parameters used in this research.
Analysis predicted descriptors for oral systemic drugs
The experimental %ABS was correlated with the predicted 
pharmacokinetic parameters and analyzed using Microsoft Excel. The 
resulting scatter plot showed the correlation coefficient (R) between 
the experimental %ABS with the descriptors of oral systemic drugs. 
Furthermore, SPSS was used to calculate significant values (*p). If 
*p-value was <0.05, the result was considered statistically significant.
RESULTS AND DISCUSSION
Preparation of experimental pharmacokinetic parameters
Experimental pharmacokinetic parameters were obtained from the 
study by Zhao et al. and previous studies (Table 1).
Validation of predicted pharmacokinetic parameters
MW, logP, HBA, HBD, and PSA can be predicted using QikProp, 
SwissADME, Molinspiration, and Chemicalize. Further, pKa can be 
predicted using Chemicalize. Caco2 permeability can be predicted using 
QikProp, admetSAR, and pkCSM.
Optimization of predicted pharmacokinetic parameters
SwissADME is the most accurate software in predicting MW, logP, and 
HBD. Chemicalize is the most accurate software in predicting HBA, 
Table 1: Reference prediction pharmacokinetic parameters
Drugs % ABS (g/mol)a MWb logPc HBAd HBDe LR5f PSA (Å²)g pKah Caco2 permeability (10−6 cm/s)i
Aminopyrine 100 231 1 4 0  25 5.00 −4.44
Cromolyn sodium 0.4 468 1.92 11 3  167 - −6.89
Ibuprofen 95 206 3.5 2 1  40 4.60 −4.58
Indomethacin 100 358 4.27 5 1  68 4.50 −4.89
Isoxicam 100 335 2.83 8 2  116 - −5.61
Ketorolac 90 225 1.62 4 1  62 4.47 -
Lornoxicam 100 372 3.15 7 2  100 4.70 -
Meloxicam 90 351 3.01 7 2  101 4.20 −4.71
Naproxen 99 230 3.34 3 1  51 4.27 −4.66
Oxatomide 100 426 5.41 5 1  44 - -
Piroxicam 100 331 1.98 7 2  99 5.28 −4.33
Salicylic acid 100 138 2.26 3 2  55 2.85 −4.82
Sulindac 90 356 2.81 3 1  58 4.70 -
Tenidap 89 321 0.63 5 3  77 4.50 −4.57
Tenoxicam 100 337 2.42 7 2  100 4.42 -
Theophylline 100 180 −0.02 6 1  64 8.51 −4.61
Ciprofloxacin 69 331 −1.08 6 2  77 6.16 −5.9
Doxorubicin 12 543 0.1 12 7 alert 204 8.20 −6.48
Cyclosporine 28 1202 3.8 23 5 alert 324 - −6.05
Methotrexate 70 454 −0.3 13 7 alert 211 3.30 −6.1
Lansoprazole 85 369 3.07 5 1  65 3.83 -
Omeprazole 80 345 2.23 6 1  72 4.25 -
Dexamethasone 80 392 2.01 5 3  90 6.00 −4.91
Hydrocortisone 91 362 1.61 5 3  96 - −4.82
Methylprednisolone 82 374 1.96 5 3  95 - −4.93
Prednisolone 99 360 1.62 5 3  97 - −4.72
Cimetidine 64 252 0.4 6 3  84 6.93 −5.9
Famotidine 38 337 −0.57 9 8  182 6.74 −6.16
Nizatidine 90 331 0.5 7 2  83 13.23 -
Ranitidine 64 314 0.27 7 2  82 13.26 −6.31
Metaproterenol 44 211 0.08 4 4  81 4.30 −6.42
Terbutaline 62 225 0.08 4 4  80 8.79 −6.16
aAbsorption data were taken from Reference [13], bmolecular weight data were taken from reference [13], clogP data were taken from Reference [13], dhydrogen bond 
acceptor (HBA) data were taken from reference [13], ehydrogen bond donor (HBD) data were taken from reference [13], fLipinski’s rule of five (RO5) data were taken 
from Reference [13]. Checkmark () means the compound fulfilled the rule, gpolar surface area (PSA) data were taken from reference [13], hpKa data were taken from 
reference [14-33], iCaco2 permeability data were taken from reference [34,35], -No data, ABS: Absorption
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PSA, and pKa. Furthermore, admetSAR is the most accurate software 
in predicting Caco2 permeability. Fig. 1 shows the correlation between 
experimental data and predicted data.
The correlation between reference MW and predicted MW showed 
R=0.9985; the correlation between reference logP and predicted 
logP showed R=0.8694; the correlation between reference HBA and 
predicted HBA showed R=0.8716; the correlation between reference 
HBD and predicted HBD showed R=0.9253; the correlation between 
reference PSA and predicted PSA showed R=0.9916; the correlation 
between reference pKa and predicted pKa showed R=0.6463; and the 
correlation between reference Caco-2 permeability and predicted Caco-
2 permeability showed R=0.8593.
Analysis predicted descriptors for oral systemic drugs
The correlation between %ABS and predicted pharmacokinetic 
parameters was analyzed using Microsoft Excel. The correlation 
between %ABS and predicted MW showed R=−0.4773; the correlation 
%ABS percentage and predicted logP showed R=0.3534; the 
correlation between %ABS and predicted HBA showed R=−0.7205; 
the correlation between %ABS and predicted HBD showed 
R=−0.7046; the correlation between %ABS and predicted PSA 
showed R=−0.6627; the correlation between %ABS and predicted pKa 
showed R=−0.5453; and the correlation between %ABS and predicted 
Caco-2 permeability showed R=0.8211 (Fig. 2).
Table 2 indicates the two absorption multiple regression models obtained 
in this research. Model 1 was created with all compounds with complete 
parameters and model 2 was created with all compounds with complete 
parameters but without 100% absorption. From the data, multiple 
regressions derived better R2 value were obtained from model 2 than 
from model 1 (0.792948 and 0.750249, respectively). However, because 
the standard errors for the models were similar (17.22067 and 17.57382, 
respectively), the differences were not statistically significant. Further, the 
weightages of several parameters in model 2 were larger than those in 
model 1 and LogP, Caco2, and pKa were noticeably larger than the others. 
Absorption multiple regression results are listed in Table 2.
DISCUSSION
The correlation between reference MW and predicted MW; reference 
logP and predicted logP; reference HBA and predicted HBA; reference 
HBD and predicted HBD; reference PSA and predicted PSA; and 
reference Caco-2 permeability and predicted Caco-2 permeability 
showed strong correlations with R=0.9985, 0.8694, 0.8716, 0.9253, 
0.9916, and 0.8593, respectively; however, the correlation between 
reference pKa and predicted pKa showed medium correlation with 
R=0.6463. Therefore, predicted pKa showing R value (<0.7) is the 
only parameter that exhibits a moderate positive relationship [36]. 
Several researches mention the accuracy problem of pKa prediction 
and state that pKa prediction is highly dependent on the dataset [37]. 
The simplification of the software calculation may also be a limitation 
of pKa prediction [38]. To improve the algorithm, drug type clustering 
based on its pKa level should be considered because the algorithm 
may show different results for acidic and basic drugs. The pKa range of 
clusterization should be optimized in further research. In addition, the 
dataset in this experiment contains various compounds that may act as 
obstacles in accurate pKa prediction for all structures. In this study, pKa 
of several compounds, such as aminopyrine with anti-inflammatory 
action; hydrocortisone, methylprednisolone, and prednisolone, which 
are corticosteroid agents; and nizatidine and ranitidine from H2 
receptor antagonist group, could not be accurately predicted. The R 
value is suggested to reach >0.9 to be considered as accurate prediction.
From this research, we found that the various software programs 
provided different parameter prediction results. None of the software 
served as the most accurate prediction tool for all parameters. However, 
out of seven parameters, Chemicalize and SwissADME accurately 
predicted three complimentary parameters each. Moreover, Caco2 
prediction only can be accurately done using admetSAR.
Analysis descriptors for the 34 oral systemic drugs resulting in the 
highest R value were the significant correlation between %ABS and 
Caco-2 permeability (R=0.8211; *p<0.001) (Fig. 2).
The absorption multiple regression models were derived from these 
data by including the compounds with 100% absorption (model 1) 
or excluding it (model 2) to observe how the nonlinear function part 
affects the correlation. Better R2 values were obtained from model 2 
than from model 1; however, the difference was not significant. Further, 
the weightages of several parameters in model 2 were larger than those 
in model 1, with LogP, Caco2, and pKa being noticeably larger than the 
others. This suggests that these three parameters, as opposed to MW 
and PSA, have higher tendencies to affect absorption.
In general, a model is acceptable if it has R2>0.6 [39]. In addition, in this 
case, good model fitness was observed in both models. This study is limited 
by its small dataset and usually good prediction is statistically derived from 
large datasets; therefore, further considerations need to be undertaken 
such as to selectively include various drugs and also to try several other 
software programs not included in this study. Nevertheless, from the 
experiment, both models are acceptable to be used as early in silico tools to 
assist the prediction of the absorption of systemic oral drugs.
Fig. 1: Scatter plot reference polar surface area (PSA) [4] versus 
predicted PSA
Fig. 2: Scatter plot absorption percentage versus predicted Caco-2 
permeability
Table 2: Multiple regression model of absorption made from 
calculated parameters
No. Model R2 n SE










MW: Molecular weight, HBA: Hydrogen bond acceptor, HBD: Hydrogen bond 
donor, PSA: Polar surface area, ABS: Absorption
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CONCLUSION
Parameter prediction was successfully performed in this research. 
SwissADME was the most accurate software in predicting MW, logP, 
and HBD; Chemicalize was the most accurate software in predicting 
HBA, PSA, and pKa; and admetSAR was the most accurate software in 
predicting Caco2 permeability. The highest R value was obtained from 
the significant correlation between %ABS and Caco-2 permeability of 
34 drug compounds (R=0.8211; *p<0.001). These results indicate that 
the %ABS of oral systemic drugs is affected by Caco-2 permeability.
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